Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Adaptimmune Therapeutics plc (ADAP)

3.95   -0.03 (-0.75%) 02-20 16:00
Open: 3.96 Pre. Close: 3.98
High: 4.0081 Low: 3.84
Volume: 545,028 Market Cap: 512M
Adaptimmune Therapeutics PLC along with its subsidiaries is a clinical-stage biopharmaceutical company. It is engaged in novel cancer immunotherapy products based on its T-cell receptor platform.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 4.014 - 4.047 4.047 - 4.069
Low: 3.773 - 3.809 3.809 - 3.833
Close: 3.903 - 3.959 3.959 - 3.996

Technical analysis

as of: 2020-02-20 4:37:28 PM
Overall:       
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 5.04     One year: 5.64
Support: Support1: 3.48    Support2: 2.90
Resistance: Resistance1: 4.31    Resistance2: 4.83
Pivot: 4.08
Moving Average: MA(5): 3.99     MA(20): 4.04
MA(100): 1.91     MA(250): 2.79
MACD: MACD(12,26): 0.30     Signal(9): 0.42
Stochastic oscillator: %K(14,3): 24.63     %D(3): 30.76
RSI: RSI(14): 57.92
52-week: High: 6.00  Low: 0.71  Change(%): -13.6
Average Vol(K): 3-Month: 210760  10-Days: 52340

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
ADAP has closed above bottom band by 27.2%. Bollinger Bands are 49.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to ADAP's normal range. The bands have been in this narrow range for 2 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Thu, 20 Feb 2020 11:19:00 +0000
3 Biotech Stocks That Have Already Doubled This Year

Mon, 17 Feb 2020 14:57:00 +0000
6 Healthcare Stocks That Could Make You Filthy Rich

Sun, 09 Feb 2020 13:29:00 +0000
3 Top Biotech Stocks to Buy in February

Wed, 22 Jan 2020 20:31:49 +0000
Health Care Sector Update for 01/22/2020: NTRP,ADAP,AKCA,IONS,HCM

Wed, 22 Jan 2020 18:32:06 +0000
Consumer Sector Update for 01/22/2020: ADAP,AKCA,HCM

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  Nasdaq Global Select
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 129.51
Shares Float (M) 62.34
% Held by Insiders 0.21
% Held by Institutions 51.93
Shares Short (K) 1530
Shares Short P. Month (K)

Stock Financials

EPS -1.391
Book Value (p.s.) 1.400
PEG Ratio -2.92
Profit Margin
Operating Margin -7555.85
Return on Assets (ttm) -34.2
Return on Equity (ttm) -67.9
Qtrly Rev. Growth -99.4
Gross Profit (p.s.) -0.299
Sales Per Share
EBITDA (p.s.) -1.031
Qtrly Earnings Growth
Operating Cash Flow (M) -131.66
Levered Free Cash Flow (M) -85.61

Stock Valuations

P/E -2.84
P/E Growth Ratio -0.01
P/BV 2.82
P/S 197.49
P/CF -3.89

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date 2018-03-29
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.